$LONA
LeonaBio, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Bothell, WA
LONA chart
What traders are saying about $LONA
Latest postsLeonaBio, Inc. news
- At $0.001 a share, Sermonix exercises warrants for LeonaBio (LONA) stock.
Stock Titan ·
- Perceptive Advisors Executes 776,648 LeonaBio Pre-Funded Warrants, Reports Key Ownership Updates
Kalkine Media ·
- Perceptive Xontogeny Venture Fund II Obtains 2,352,932 LeonaBio Pre-Funded Warrants
Kalkine Media ·
- LeonaBio to Participate in Cantor Global Healthcare Conference 2026
Yahoo Finance ·
- LeonaBio beats Q2 loss forecast as Phase 3 ELAINE-3 trial advances
investorshub.advfn.com ·
- LeonaBio Reports Second Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer at DAVA Oncology’s 4th Summit on Breast Cancer
Yahoo Finance ·
- LeonaBio Presents on ATH-1105 at 5th Annual ALS Drug Development Summit
Yahoo Finance ·
- LeonaBio to Participate in Upcoming Medical and Industry Meetings in June
Yahoo Finance ·
- LeonaBio Reports First Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- LeonaBio Enhances Board of Directors with Appointments of Fred Callori, J.D., Natalie Holles and Peter B. Silverman, J.D.
Yahoo Finance ·
- LeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatment-Resistant ER+/HER2-, ESR1-Mutated Metastatic Breast Cancer
Yahoo Finance ·
LeonaBio, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$106.0M | -$97.0M | -$117.7M | -$95.6M |
| Diluted EPS | $-24.70 | $-25.19 | $-3.09 | $-2.53 |
| Total assets (year end) | $92.2M | $58.8M | $160.2M | $258.2M |
| Cash and equivalents (year end) | $69.3M | $48.4M | $90.6M | $96.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About LeonaBio, Inc.
- Ticker
- LONA (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Bothell, WA
- Fiscal year end
- December 31
- SEC CIK
- 1620463
- Former names
- Athira Pharma, Inc., M3 Biotechnology, Inc.
Frequently asked questions
What exchange is LeonaBio, Inc. listed on?
LeonaBio, Inc. trades on the Nasdaq under the ticker symbol LONA.
What industry is LeonaBio, Inc. in?
LeonaBio, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is LeonaBio, Inc. headquartered?
LeonaBio, Inc.'s business address on file with the SEC is in Bothell, WA.
When does LeonaBio, Inc.'s fiscal year end?
LeonaBio, Inc.'s fiscal year ends on December 31.